HWM
ABBV icon

Horizon Wealth Management’s AbbVie ABBV Stock Holding History

Horizon Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$813K Buy
3,738
+8
+0.2% +$1.77K 0.12% 64
2025
Q4 		$852K Buy
3,730
+5
+0.1% +$1.14K 0.13% 54
2025
Q3 		$863K Buy
3,725
+89
+2% +$18.1K 0.13% 51
2025
Q2 		$675K Sell
3,636
-106
-3% -$19.7K 0.12% 48
2025
Q1 		$784K Buy
3,742
+117
+3% +$22.7K 0.13% 38
2024
Q4 		$644K Buy
3,625
+158
+5% +$29K 0.11% 42
2024
Q3 		$685K Buy
3,467
+13
+0.4% +$2.43K 0.14% 39
2024
Q2 		$592K Sell
3,454
-54
-2% -$8.95K 0.14% 35
2024
Q1 		$639K Buy
3,508
+111
+3% +$19.1K 0.17% 34
2023
Q4 		$526K Sell
3,397
-19
-0.6% -$2.77K 0.15% 38
2023
Q3 		$509K Buy
3,416
+16
+0.5% +$2.35K 0.2% 34
2023
Q2 		$458K Buy
3,400
+16
+0.5% +$2.35K 0.18% 37
2023
Q1 		$539K Buy
3,384
+16
+0.5% +$2.45K 0.4% 31
2022
Q4 		$544K Sell
3,368
-138
-4% -$21.2K 0.44% 27
2022
Q3 		$471K Sell
3,506
-1,544
-31% -$222K 0.35% 31
2022
Q2 		$773K Buy
5,050
+804
+19% +$123K 0.32% 41
2022
Q1 		$688K Buy
4,246
+13
+0.3% +$1.89K 0.21% 44
2021
Q4 		$573K Buy
+4,233
New +$500K 0.17% 52

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Horizon Wealth Management's ABBV Position: Q1 2026 in Review

Horizon Wealth Management increased its AbbVie (ABBV) stake by 0.21% in Q1 2026, buying an estimated $1.77K and bringing the position to 3,738 shares worth $813K. The position accounts for 0.12% of the portfolio, ranked #64.

Horizon Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $863K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Horizon Wealth Management held 3,738 shares of AbbVie worth $813K as of Q1 2026.
  • Horizon Wealth Management bought 8 AbbVie shares in Q1 2026, an estimated $1.77K.
  • AbbVie made up 0.12% of Horizon Wealth Management's portfolio in Q1 2026, its #64 holding.
  • Horizon Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Horizon Wealth Management's AbbVie position peaked at $863K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Horizon Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.